Literature DB >> 19821707

High use of complementary and alternative medicine inside and outside of the government-funded health care system in Norway.

Vinjar Fønnebø1, Laila Launsø.   

Abstract

OBJECTIVES: The objective of this study was to describe the Norwegian population's use of complementary and alternative medicine (CAM) inside as well as outside of the health care system in Norway over the previous 12 months.
DESIGN: A survey based on telephone interviews has been conducted.
SETTING: The interviewees were sampled from the 97% of Norwegians aged 15 years or more living in private households with a landline telephone or a cell phone.
SUBJECTS: In total, 9035 individuals were called in order to include 1007 individuals in the sample. OUTCOME MEASURE: The main outcome measure was the proportion receiving CAM given by a CAM practitioner over the previous 12 months. The interviews were made by trained interviewers in March 2007 by Synovate MMI for NAFKAM.
RESULTS: "Over the previous 12 months," 48.7% of the respondents had received CAM by CAM practitioners outside of or by health care personnel inside the health care system. Approximately 18% had received CAM by providers four or more times "over the previous 12 months." The highest proportion of female users of CAM can be found in 15-24-year-olds.
CONCLUSIONS: The high use of CAM provided by CAM practitioners outside of as well as by health care providers inside the health care system indicates that users do not see themselves as belonging to one or the other system; they have already combined both systems when designing their own care.

Mesh:

Year:  2009        PMID: 19821707     DOI: 10.1089/acm.2008.0632

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  8 in total

1.  Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD.

Authors:  Agnete E Kristoffersen; Arne J Norheim; Vinjar M Fønnebø
Journal:  BMC Complement Altern Med       Date:  2012-01-12       Impact factor: 3.659

2.  Types of treatment collaboration between conventional and alternative practitioners-results from a research project at a Danish MS hospital.

Authors:  Lasse Skovgaard; Niels Haahr; Liv Bjerre; Laila Launsø
Journal:  Int J Integr Care       Date:  2010-12-23       Impact factor: 5.120

3.  Understanding unexpected courses of multiple sclerosis among patients using complementary and alternative medicine: A travel from recipient to explorer.

Authors:  Anita Salamonsen; Laila Launsø; Tove E Kruse; Sissel H Eriksen
Journal:  Int J Qual Stud Health Well-being       Date:  2010-07-02

4.  Use of complementary and alternative medicine at Norwegian and Danish hospitals.

Authors:  Laila J Salomonsen; Lasse Skovgaard; Søren la Cour; Lisbeth Nyborg; Laila Launsø; Vinjar Fønnebø
Journal:  BMC Complement Altern Med       Date:  2011-01-18       Impact factor: 3.659

5.  Management of primary chronic headache in the general population: the Akershus study of chronic headache.

Authors:  Espen Saxhaug Kristoffersen; Ragnhild Berling Grande; Kjersti Aaseth; Christofer Lundqvist; Michael Bjørn Russell
Journal:  J Headache Pain       Date:  2011-10-13       Impact factor: 7.277

6.  Self-reported efficacy of complementary and alternative medicine: the Akershus study of chronic headache.

Authors:  Espen Saxhaug Kristoffersen; Kjersti Aaseth; Ragnhild Berling Grande; Christofer Lundqvist; Michael Bjørn Russell
Journal:  J Headache Pain       Date:  2013-04-18       Impact factor: 7.277

7.  Use of complementary and alternative medicine within Norwegian hospitals.

Authors:  R Jacobsen; V M Fønnebø; N Foss; A E Kristoffersen
Journal:  BMC Complement Altern Med       Date:  2015-08-13       Impact factor: 3.659

8.  Placebo by proxy expectations toward acupuncture change over time: a survey comparing parental expectations to acupuncture pre- and postoperatively.

Authors:  Ingrid Liodden; Are Hugo Pripp; Arne Johan Norheim
Journal:  BMC Complement Altern Med       Date:  2018-06-14       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.